WeightWatchers Review
Best for: Foundayo access with a structured behavior-change program
WeightWatchers offers Foundayo (orforglipron) through its Med+ program, with care delivered by the WeightWatchers Clinic affiliate medical group. Foundayo is self-pay at $149/mo for the starting dose and up to $299/mo at higher doses, billed separately from the Med+ membership ($25 first month, $74/mo after with a 12-month commitment). WW is one of the few non-pharmacy telehealth programs that lists Foundayo transparently.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
WeightWatchers stands out for its medical oversight and pharmacy verification.
Score Breakdown
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| Foundayo starting dose (0.8mg / 2.5mg) | brand | $149 |
| Foundayo higher doses (5.5mg - 17.2mg) | brand | $299 |
✓ Pros
- •One of the first non-pharmacy telehealth programs to list Foundayo transparently
- •Care delivered by WeightWatchers Clinic (affiliated medical group)
- •Supports all 6 Foundayo doses: 0.8mg, 2.5mg, 5.5mg, 9mg, 14.5mg, 17.2mg
- •Publishes self-pay drug price on the product page (rare for a telehealth program)
- •Combines pharmacotherapy with the WW Points/behavior-change program
✗ Cons
- •Med+ membership ($25 first month, $74/mo ongoing) is billed separately from the drug cost — actual out-of-pocket is higher than the listed $149/mo
- •State availability list not published publicly — requires eligibility quiz
- •Insurance coverage for Foundayo not yet available per WW's own disclosure
- •No compounded GLP-1 option; Foundayo only
- •12-month Med+ commitment required to lock the introductory $25 price
Ready to start with WeightWatchers?
Starting at $149/month. See current pricing and start your free consultation.
Sources & methodology
Our WeightWatchers review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of April 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
Frequently Asked Questions
Ready to start with WeightWatchers?
Starting at $149/month. See current pricing and start your free consultation.